ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome

Project Number
20141208-BLACK-2014
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Year
2014
View Full Project Details for ADD ON: Sartans to Slow Alzheimer's Disease: A Randomized, Open-Label, Head-to-Head, Proof-of-Concept Study of Angiotensin Receptor Blockers Versus ACE Inhibitors in Hypertensive Mild-Moderate AD Patients using Ventricular Enlargement as Primary Outcome
Research Categorization
Primary Disease / Condition
Alzheimer's Disease
Vascular Dementia/Dysfunction
CADRO
Category C. Translational Research and Clinical Interventions
7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials)
k. Vasculature
Researcher and Organization
Principal Investigator
Black, Sandra
Principal Investigator First Name
Sandra
Principal Investigator Last Name
Black
Awardee Organization
Sunnybrook Health Sciences Centre
Contact PI Country
Canada
Project Detail
Funding Opportunity Announcement
PACT RFP
FY Overall Cost
$450,000
Funding Organization
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Organization Country
United States

You might be interested in other related resources and tools...